Ligand id: 5082

Name: trastuzumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: trastuzumab

1. EMA. 
Accessed on 08/02/2018. Modified on 08/02/2018. European Medicines Agency,
2. Hudziak RM, Shepard HM, Ullrich A. (1989)
Method of treating tumor cells by inhibiting growth factor receptor function.
Patent number: WO1989006692. Assignee: Genentech Inc. Priority date: 12/01/1988. Publication date: 27/07/1989.
3. Paplomata E, Nahta R. (2018)
ABP 980: promising trastuzumab biosimilar for HER2-positive breast cancer.
Expert Opin Biol Ther, : 1-7 [Epub ahead of print]. [PMID:29350568]